Richard A. Lake

Richard A. Lake publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard A. Lake sits on this spectrum.

Richard A. Lake D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard A. Lake sits on this spectrum.

Best Publications

• Immunotherapy and chemotherapy — a practical partnership

  Richard A. Lake;Bruce W.S. Robinson

  781
  Citations

• Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells

  Anna K Nowak;Richard A Lake;Amanda L Marzo;Amanda L Marzo;Bernadette Maree Scott;Bernadette Maree Scott

  556
  Citations

• Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.

  Anna K Nowak;Bruce W S Robinson;Richard A Lake

  513
  Citations

• Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

  Amanda L. Marzo;Beverley F. Kinnear;Richard A. Lake;Jeffrey J. Frelinger

  468
  Citations

• Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

  Esdy N. Rozali;Stanleyson V. Hato;Bruce W. Robinson;Richard A. Lake

  371
  Citations

• Gemcitabine Exerts a Selective Effect on the Humoral Immune Response Implications for Combination Chemo-immunotherapy

  Anna K Nowak;Bruce W S Robinson;Richard A Lake

  297
  Citations

• Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity.

  W. Joost Lesterhuis;Anthony Bosco;Michael J. Millward;Michael J. Millward;Michael Small;Michael Small

  241
  Citations

• Tumor Antigens are Constitutively Presented in the Draining Lymph Nodes

  Amanda L. Marzo;Richard A. Lake;David Lo;Linda Sherman

  217
  Citations

• Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment

  Rachael M. Zemek;Emma De Jong;Wee Loong Chin;Wee Loong Chin;Iona S. Schuster;Iona S. Schuster;Iona S. Schuster

  204
  Citations

• Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action

  Unknown

  193
  Citations

• Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy

  Robbert G. van der Most;Robbert G. van der Most;Andrew J. Currie;Sathish Mahendran;Amy Prosser

  177
  Citations

• New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.

  Anna K. Nowak;Richard A. Lake;Hedy Lee Kindler;Bruce W.S. Robinson

  164
  Citations

• Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity

  W. Joost Lesterhuis;W. Joost Lesterhuis;Joanne Salmons;Anna K. Nowak;Anna K. Nowak;Esdy N. Rozali

  161
  Citations

• T-Cell Receptor Transgenic Analysis of Tumor-specific CD8 and CD4 Responses in the Eradication of Solid Tumors

  Amanda L. Marzo;Richard A. Lake;Bruce W. S. Robinson;Bernadette Scott

  161
  Citations

• Chemotherapy and immunotherapy: Mapping the road ahead

  Alistair M Cook;W Joost Lesterhuis;Anna K Nowak;Anna K Nowak;Richard A Lake

  140
  Citations

• Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: Persistent transgene expression despite antibody generation

  Sutapa Mukherjee;Thomas Haenel;Robyn Himbeck;Bernadette Scott

  136
  Citations

• Immunogenic anti-cancer chemotherapy as an emerging concept

  Nicole M Haynes;Robbert G van der Most;Richard A Lake;Mark J Smyth

  127
  Citations

• Combined chemoimmunotherapy of solid tumours: improving vaccines?

  Anna K. Nowak;Richard A. Lake;Bruce W.S. Robinson

  126
  Citations

• Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.

  Robbert G. van der Most;Andrew J. Currie;Amanda L. Cleaver;Joanne Salmons

  123
  Citations

• Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity.

  Robbert G. van der Most;Andrew Currie;Bruce W.S. Robinson;Richard A. Lake

  122
  Citations